Diagnostic Criteria for Hepatitis
The diagnosis of hepatitis requires detection of specific viral markers combined with evidence of liver inflammation through elevated aminotransferases (ALT/AST) and clinical assessment, with diagnostic criteria varying by hepatitis type.
Hepatitis B Diagnostic Criteria
For chronic hepatitis B, the diagnosis requires 1:
- HBsAg positive for >6 months
- Serum HBV DNA >20,000 IU/ml (though lower values of 2,000-20,000 IU/ml are often seen in HBeAg-negative chronic hepatitis B)
- Persistent or intermittent elevation in ALT/AST levels
- Liver biopsy showing chronic hepatitis with moderate or severe necroinflammation (when indicated)
Additional HBV Testing Components
The initial evaluation must include 1:
- HBeAg/anti-HBe status to determine disease phase
- HBV DNA quantification using PCR-based assays (sensitivity 50-200 IU/ml, with newer real-time PCR achieving 5-10 IU/ml)
- Complete blood counts with platelets, hepatic panel, and prothrombin time to assess liver disease severity
- Anti-HCV, anti-HDV (in high-risk populations), and anti-HIV testing to rule out coinfections
- AFP and ultrasound for HCC screening in high-risk patients
Important HBV Diagnostic Distinctions
Inactive HBsAg carrier state differs from chronic hepatitis B and requires 1:
- HBsAg positive >6 months
- HBeAg negative, anti-HBe positive
- Serum HBV DNA <2,000 IU/ml
- Persistently normal ALT/AST levels
- Liver biopsy confirming absence of significant hepatitis
Critical pitfall: Serial monitoring of HBV DNA levels is more important than any single arbitrary cutoff value, as patients can have widely fluctuating levels (undetectable to >2,000 IU/ml). Lower HBV DNA levels (3-5 log10 IU/ml) may still be associated with progressive liver disease, particularly in HBeAg-negative patients or those with cirrhosis 1.
Hepatitis C Diagnostic Criteria
For acute HCV infection, interpretation requires 2:
- HCV antibody: May be negative during first 6 weeks after exposure; seroconversion may be delayed/absent in immunosuppressed individuals; presence alone does not distinguish acute vs. chronic infection
- HCV RNA: Viral fluctuations >1 log10 IU/mL may indicate acute infection; may be transiently negative during acute HCV; presence alone does not distinguish acute vs. chronic infection
- ALT: Fluctuating ALT peaks suggest acute infection; may be normal during acute HCV; may be elevated due to other causes (e.g., alcohol)
HCV Testing Strategy
For chronic HCV diagnosis 3:
- Screening: Third-generation EIA (enzyme immunoassay) detecting anti-HCV antibodies from core, NS3, NS4, and NS5 genes
- Confirmation: HCV RNA detection by PCR (sensitivity <100 copies/ml) provides evidence of active infection
- Supplemental testing: RIBA (recombinant immunoblot assay) to resolve false-positive EIA results in low-prevalence settings
Hepatitis A Diagnostic Criteria
Hepatitis A diagnosis requires 4:
- Detection of IgM antibody to HAV in a patient with clinical features of hepatitis (icteric or anicteric disease)
- Serum ALT and AST rise rapidly during prodrome, reach peak levels, then decrease by ~75% per week
- Serum bilirubin peaks later and declines less rapidly than aminotransferases
- Mean incubation period: ~30 days
- Jaundice persists <2 weeks in ~85% of cases
Non-ABCDE Hepatitis
Diagnostic criteria require exclusion of hepatitis A, B, C, D, and E using both serological and molecular diagnosis 5. Molecular diagnosis directly detects viral components and can demonstrate appearance/disappearance of viruses, overcoming pseudonegative serological results.
Assessment of Liver Disease Severity
Noninvasive tests to assess disease severity include 2:
- Liver-directed physical examination
- Routine blood tests: ALT, AST, albumin, bilirubin, INR, CBC with platelet count
- Serum fibrosis marker panels
- Transient elastography
- APRI (AST-to-platelet ratio index)
- FIB-4 score
- Liver imaging (ultrasound or CT scan)
Key caveat: In HIV/HBV coinfection, test all HIV-infected persons for both HBsAg and anti-HBc; if either is positive, test for HBV DNA, as "occult HBV" can occur with high HBV DNA levels but negative HBsAg 1.